Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 14, 2026, FDA's public records list Nova Labs Ltd with 2 drug applications.
Drug applications: 2
Records by Year
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
02017Records0
020182018Records0vs 2017+0
02019Records0vs 2018+0
020202020Records0vs 2019+0
02021Records0vs 2020+0
020222022Records0vs 2021+0
02023Records0vs 2022+0
120242024Records1vs 2023+1
02025Records0vs 2024−1
020262026 to dateRecords0
Latest Records
Newest first across sources; each opens the record
FDA's databases did not answer. Reload in a moment.
Orphan Designations (FDA)
3 designations since 1983, 3 approved for the designated use, matched by the sponsor's name; see all orphan designations
XromiTreatment of sickle cell anemia in pediatric patients · Mar 2, 2017 · approved Dec 23, 2024
XromiTreatment of sickle cell anemia in pediatric patients · Mar 2, 2017 · approved Apr 4, 2024
PurixanTreatment of acute lymphoblastic leukemia in pediatric patients · Aug 20, 2012 · approved Apr 28, 2014
Names and Identifiers
Appears as
NOVA LABS LTD
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.How this page is built
